Cui, Jia
Sendinc, Erdem
Liu, Qi
Kim, Sujin
Fang, Jaden Y.
Gregory, Richard I. http://orcid.org/0000-0001-8090-8673
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R35CA232115)
Article History
Received: 29 June 2023
Accepted: 25 June 2024
First Online: 10 July 2024
Competing interests
: R.I.G. is a co-founder, scientific advisory board member, and equity holder of Redona Therapeutics. The Gregory lab receives or has received research funding from Sanofi, Astellas, and Ono. All other authors declare no competing interests.